financetom
Business
financetom
/
Business
/
Cintas Lifts Fiscal 2026 Outlook Following First-Quarter Beat
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cintas Lifts Fiscal 2026 Outlook Following First-Quarter Beat
Sep 24, 2025 7:42 AM

10:18 AM EDT, 09/24/2025 (MT Newswires) -- Cintas ( CTAS ) raised its full-year outlook on Wednesday as the uniform supplier reported fiscal first-quarter results above Wall Street's expectations.

Earnings are now anticipated to come in between $4.74 and $4.86 per share for fiscal 2026, up from the company's previous projections of $4.71 to $4.85, Chief Executive Todd Schneider said in a statement. Revenue is pegged at $11.06 billion to $11.18 billion versus the prior guidance range of $11 billion to $11.15 billion, according to Schneider.

The current consensus on FactSet is for EPS of $4.84 and sales of $11.11 billion for the ongoing fiscal year. The company's revenue outlook assumes no acquisitions in the future and a constant foreign currency exchange rate, it said.

For the quarter ended August, Cintas' ( CTAS ) EPS rose to $1.20 from $1.10 the year before, topping the Street's view for $1.19. Revenue advanced 8.7% to $2.72 billion, ahead of the average analyst estimate of about $2.7 billion, buoyed by a 0.9% gain from acquisitions. Organic revenue growth was 7.8%.

"In the first quarter, we achieved strong revenue growth, along with healthy margin expansion, reflecting our disciplined execution, ongoing investment in technology and talent," Schneider said. "Our results reflect the strength of our value proposition and demonstrate the value we deliver to customers across all segments."

Sales from uniform rental and facility services climbed 8.1% to $2.09 billion, while first aid and safety services inclined to $334.7 million from $292.6 million a year earlier.

Gross margin as a percentage of revenue was 50.3% for the quarter, compared with 50.1% in the prior-year period. Selling and administrative expenses rose to $748.7 million from $691.1 million.

"We continue to position Cintas ( CTAS ) for sustainable growth and long-term value creation," according to Schneider. "Our ability to generate robust cash flow has enabled us to pursue balanced capital allocation - investing in our future while returning capital to shareholders."

Price: 201.43, Change: +0.84, Percent Change: +0.42

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Liberty Defense Up Near 14% On Contract Win for Multiple HEXWAVE Walkthrough Screening Systems From a U.S. State Capitol Complex
Liberty Defense Up Near 14% On Contract Win for Multiple HEXWAVE Walkthrough Screening Systems From a U.S. State Capitol Complex
Nov 17, 2025
03:04 PM EST, 11/17/2025 (MT Newswires) -- Liberty Defense Holdings ( LDDFF ) shares were up near 14% on Monday after it received a competitive bid award for three HEXWAVE walkthrough screening systems at a U.S. State Capitol complex in the Northeast. The company said the systems will support security screening for officials, employees, and visitors across two high-traffic buildings....
Target May Tighten 2025 Outlook as Q3 Comps Stay Weak, Oppenheimer Says
Target May Tighten 2025 Outlook as Q3 Comps Stay Weak, Oppenheimer Says
Nov 17, 2025
02:46 PM EST, 11/17/2025 (MT Newswires) -- Target ( TGT ) is likely to post soft Q3 on Wednesday with comparable sales down about 2% and could narrow its fiscal 2025 earnings per share guidance toward the low end of its $7 to $9 range, Oppenheimer said Monday in a pre-results report. Oppenheimer said it added conservatism to its Q4...
Jones Lang LaSalle Offers Steady Growth Outlook, UBS Says
Jones Lang LaSalle Offers Steady Growth Outlook, UBS Says
Nov 17, 2025
02:58 PM EST, 11/17/2025 (MT Newswires) -- Jones Lang LaSalle ( JLL ) is set to benefit from improving industry tailwinds amid attractive valuation after its Q3 results, UBS Securities said in a Sunday note. The report pointed to an outlook downgrade for its Real Estate Management Services segment for the next several quarters while Q3 margin expansion disappointed, similar...
Jazz Pharmaceuticals Stock Rallies On Positive Phase 3 Trial Results for Ziihera In Advanced Gastroesophageal Cancer
Jazz Pharmaceuticals Stock Rallies On Positive Phase 3 Trial Results for Ziihera In Advanced Gastroesophageal Cancer
Nov 17, 2025
Jazz Pharmaceuticals Plc ( JAZZ ) shares are popping on Monday following the company’s positive results of its Phase 3 HERIZON-GEA-01 trial, which assessed Ziihera in combination with chemotherapy, with or without the PD-1 inhibitor Tevimbra, as a first-line treatment for HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). What Happened: When compared to the control group that received trastuzumab...
Copyright 2023-2025 - www.financetom.com All Rights Reserved